by John Conrad | May 27, 2026 | iBIO in the News, Policy News
Yesterday in Springfield, iBIO President and CEO John Conrad testified on legislation that would expand and reshape how Illinois interacts with the federal 340B drug discount program—underscoring a principle iBIO believes must come first: independent, enforceable...
